Securities and Exchange Commission
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(A)
of the Securities Exchange Act of 1934
Filed by the Registrant [ ]
Filed by a Party other than the Registrant [X]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Definitive Proxy Statement
[X] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c)
or Section 240.14a-12
Circon Corporation
(Name of Registrant as Specified in its Charter)
United States Surgical Corporation
(Name of Person Filing Proxy Statement)
----------------------------
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules
14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which
transaction applies: N/A
(2) Aggregate number of securities to which
transaction applies: N/A
(3) Per unit price or other underlying value of
transaction computed pursuant to Exchange Act Rule
0-11 (Set forth the amount on which the filing fee
is calculated and state how it was determined): N/A
(4) Proposed maximum aggregate value of transaction:
N/A
(5) Total fee paid: N/A
[ ] Fee previously paid with preliminary materials.
[ ] Check box if any part of the fee is offset as
provided by Exchange Act Rule 0-11(a)(2) and
identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by
registration statement number, or the Form or
Schedule and the date of its filing.
(1) Amount previously paid:
(2) Form, Schedule or Registration Statement Number:
(3) Filing Party:
(4) Date Filed:
[U.S. Surgical Letterhead]
FOR IMMEDIATE RELEASE: October 1, 1997
INVESTOR CONTACT: U.S. SURGICAL HOME PAGE MEDIA CONTACT:
Marianne Scipione http://www.ussurg.com Steve Rose
Vice President Director
Corporate Communications Media Relations
(203) 845-1404 (203) 845-1732
[email protected] [email protected]
ISS RECOMMENDS VOTE FOR U.S. SURGICAL
SLATE AT CIRCON ANNUAL MEETING
NORWALK, Conn. United States Surgical Corporation
(NYSE:USS) announced today that Institutional Shareholder
Services (ISS), one of the nation's leading shareholder
advisory organizations specializing in proxy analysis, has
recommended that shareholders of Circon Corporation
(NASDAQ:CCON) vote on the BLUE proxy card FOR USS' two
nominees to the Circon Board and FOR USS' proposal to seek
the prompt sale of Circon . The Circon Annual Meeting will
be held Monday, October 6, 1997, at 9:00 a.m. in Santa
Barbara, California.
"We are very pleased with the ISS report," said Leon C.
Hirsch, Chairman and Chief Executive Officer of USS. "ISS
supports USS' attempt to stop the Circon Board's 'defiance of
the wishes of shareholders,' stating 'The shareholders have
spoken, but Circon is not listening.'"
United States Surgical Corporation is a diversified
surgical products company specializing in minimally invasive
technologies that improve patient care and lower health
costs.
